Abstract
Objectives: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, and sepsis is a frequent cause of death in hospitalised patients. We investigated the relationship between ALS and the subsequent risk of sepsis. Design: A retrospective cohort analysis. Setting: Patients with ALSs diagnosed between 2000 and 2010 in Taiwan National Health Insurance Research Database. Participants: We included 701 and 2804 patients as the ALS and the non-ALS groups, respectively. Outcome measures: The risk of sepsis was calculated by Cox proportional hazards regression model. Results: During the follow-up period, the incidence density rates were 77.8 and 11.1 per 1000 person-years in the ALS and non-ALS groups, respectively. After adjusting for sex, age, Charlson comorbidity index score, life-support measures, and β 2 -adrenoceptor agonists treatment, the ALS group had a higher risk of sepsis (HR=3.42; 95% CI 2.60 to 4.50) than the non-ALS group. An increase of the risk was observed in patients with ALS receiving life support treatment measures, whereas a decrease of the risk was associated with treatment of β 2 -adrenoceptor agonists. Conclusions: The risk of sepsis is associated with a prior ALS diagnosis, and may be increased by the use of life support measures and decreased by β 2 -adrenoceptor agonists.
Funding Information
  • Ministry of Health and Welfare (MOHW105-TDU-B-212-133019)
  • Academia Sinica (BM10501010037)
  • Ministry of Science and Technology, Taiwan (MOST 105-2325-B-039-003)

This publication has 23 references indexed in Scilit: